연구성과로 돌아가기

2020 연구성과 (210 / 270)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
WoS SCOPUS Document Type Document Title Abstract Authors Affiliation ResearcherID (WoS) AuthorsID (SCOPUS) Author Email(s) Journal Name JCR Abbreviation ISSN eISSN Volume Issue WoS Edition WoS Category JCR Year IF JCR (%) FWCI FWCI Update Date WoS Citation SCOPUS Citation Keywords (WoS) KeywordsPlus (WoS) Keywords (SCOPUS) KeywordsPlus (SCOPUS) Language Publication Stage Publication Year Publication Date DOI JCR Link DOI Link WOS Link SCOPUS Link
Article Persimmon (Diospyros kaki Thunb.) seed: a potential nutritional source with antioxidant and pharmaceutical activity Pulp is a major part of persimmon fruit, for which it is widely cultivated in different parts of the world. Persimmon seeds are generally discarded as waste. The objective of the present work was to investigate the nutritional, antioxidative, and pharmacological properties of the seeds of three persimmon cultivars namely Jinyeong (JYS), Yangyangdongchulsi (YYS), and Hamanmulgam (HAS). JYS (9417.87 mg.kg(-1)) contained the highest concentration of total minerals, followed by HAS and YYS. The concentration of total organic acids was also the highest in JYS (5362.43 mg.kg(-1)), while the lowest in HAS (4411.1 mg.kg(-1)). Similarly, JYS and YYS contained the highest and lowest concentrations of free sugars, respectively. On the other hand, the total free amino acid contents were the highest in YYS (336.34 mg.100 g(-1)) among the cultivars. The persimmon seeds also have good potential for scavenging free radicals and inhibiting acetylcholinesterase activity. The seeds could also be considered to be a source of a therapeutic agent against Alzheimer's disease, as the seed extract showed promising anti-acetylcholinesterase activity. The overall results of the present work provide an insight into persimmon seeds, a by-product of persimmon fruit, as a potential product in the pharmaceutical and food industries. (C) All Rights Reserved Han, C. H.; Kim, I. D.; Kwon, S. I.; Dhungana, S. K.; Jang, S. Y.; Kim, M. J.; Shin, D. H. Kyungpook Natl Univ, Sch Appl Biosci, Daegu 41566, South Korea; Kyungpook Natl Univ, Int Inst Agr Res & Dev, Daegu 41566, South Korea; Daegu Hlth Coll, Dept Clin Pathol, Daegu 41453, South Korea; Rural Dev Adm, Natl Inst Crop Sci, Miryang 50424, South Korea Dhungana, Sanjeev Kumar/O-4097-2017 57225786002; 56269995600; 57221848852; 56269940800; 59884390800; 57127351600; 7403352903 dhshin@knu.ac.kr; INTERNATIONAL FOOD RESEARCH JOURNAL INT FOOD RES J 1985-4668 2231-7546 27 6 SCIE FOOD SCIENCE & TECHNOLOGY 2020 1.014 87.1 0 2025-06-25 0 0 antioxidant; free radical scavenger; nutrition; nutraceutical; persimmon seed AMINO-ACIDS; PHENOLIC-COMPOUNDS; ORGANIC-ACIDS; EXTRACTS; METABOLISM; HEALTH; FRUITS; ASSAY free radical scavenger; nutraceutical; nutrition; persimmon seed English 2020 2020-12 바로가기 바로가기 바로가기
Article A robust approach for testing parameter change in Poisson autoregressive models Parameter change test has been an important issue in time series analysis. The problem has also been actively explored in the field of integer-valued time series, but the testing in the presence of outliers has not yet been extensively investigated. This study considers the problem of testing for parameter change in Poisson autoregressive models particularly when observations are contaminated by outliers. To lessen the impact of outliers on testing procedure, we propose a test based on the density power divergence, which is introduced by Basu et al. (Biometrika 85:549-559, 1998), and derive its limiting null distribution. Monte Carlo simulation results demonstrate validity and strong robustness of the proposed test. Kang, Jiwon; Song, Junmo Jeju Natl Univ, Dept Comp Sci & Stat, Jeju, South Korea; Kyungpook Natl Univ, Dept Stat, Daegu, South Korea 56123620200; 23470710200 jsong@knu.ac.kr; JOURNAL OF THE KOREAN STATISTICAL SOCIETY J KOREAN STAT SOC 1226-3192 2005-2863 49 4 SCIE STATISTICS & PROBABILITY 2020 0.805 87.6 0.7 2025-06-25 6 6 Testing for parameter change; Poisson AR model; Outliers; Robust test; Density power divergence TIME-SERIES Density power divergence; Outliers; Poisson AR model; Robust test; Testing for parameter change English 2020 2020-12 10.1007/s42952-020-00056-7 바로가기 바로가기 바로가기 바로가기
Article Objective Bayesian analysis using modified profile likelihood for the ratio of two log-normal means Matching priors in principle provide a possible compromise between frequentist and Bayesian and default priors for routine use in Bayesian inference in that posterior probability of the parameter also provides an interpretation as confidence statements. Here we introduce a matching prior for the ratio of two log-normal means which is nontrivial because the derivation of matching prior requires the elicitation of a suitable orthogonal parameterization on the nuisance parameters and the computation of the marginal posterior distribution requires multidimensional integration over the nuisance parameter. Numerical integrations and approximation techniques could be used but they are difficult to use in general. Thus, we derive a matching prior based on a modification of the profile likelihood to avoid the elicitation of priors for the entire parameter and integration on the nuisance parameter. The proposed method is illustrated by real data examples and simulation studies under several configurations. Kang, Sang Gil; Lee, Woo Dong; Kim, Yongku Sangji Univ, Dept Comp & Data Informat, Wonju 18950, South Korea; Daegu Haany Univ, Dept Cosmeceut Engn, Kyungsan 38610, South Korea; Kyungpook Natl Univ, Dept Stat, Daegu 41566, South Korea 56119861400; 8328822200; 47962102500 sangkg@sangji.ac.kr;wdlee@dhu.ac.kr;kim.1252@knu.ac.kr; JOURNAL OF THE KOREAN STATISTICAL SOCIETY J KOREAN STAT SOC 1226-3192 2005-2863 49 2 SCIE STATISTICS & PROBABILITY 2020 0.805 87.6 0.14 2025-06-25 4 1 Matching prior; Modified profile likelihood; Ratio of log-normal means DISTRIBUTIONS; INFERENCE Matching prior; Modified profile likelihood; Ratio of log-normal means English 2020 2020-06 10.1007/s42952-019-00028-6 바로가기 바로가기 바로가기 바로가기
Article Self-semi-supervised clustering for large scale data with massive null group In this paper, we propose self-semi-supervised clustering, a new clustering method for large scale data with a massive null group. Self-semi-supervised clustering is a two-stage procedure: preselect a part of "null" group from the data in the first stage and apply semi-supervised clustering to the rest of the data in the second stage, allowing them to be assigned to the null group. We evaluate the performance of the proposed method using a simulation study and demonstrate the method in the analysis of time course gene expression data from a longitudinal study of Influenza A virus infection. Ahn, Soohyun; Choi, Hyungwon; Lim, Johan; Lee, Kyeong Eun Ajou Univ, Dept Math, Suwon, South Korea; Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore; Seoul Natl Univ, Dept Stat, Seoul, South Korea; Kyungpook Natl Univ, Dept Stat, Daegu, South Korea Choi, Hyungwon/KVX-7893-2024 55040601100; 14065669100; 16401812900; 56041259000 johanlim@snu.ac.kr; JOURNAL OF THE KOREAN STATISTICAL SOCIETY J KOREAN STAT SOC 1226-3192 2005-2863 49 1 SCIE STATISTICS & PROBABILITY 2020 0.805 87.6 0.28 2025-06-25 3 2 Massive null group; Model-based clustering; Pre-selection; Semi-supervised clustering; Time-course microarray data; Influenza A virus MODEL; EXPRESSION; REGRESSION; FEATURES Influenza A virus; Massive null group; Model-based clustering; Pre-selection; Semi-supervised clustering; Time-course microarray data English 2020 2020-03 10.1007/s42952-019-00005-z 바로가기 바로가기 바로가기 바로가기
Article FoxP3, PD-1 and CTLA-4 are decreased significantly after a tenofovir therapy in patients with chronic hepatitis B Background: FoxP3, PD-1 and CTLA-4 are upregulated in chronic viral infections, such as chronic HCV, chronic HBV and HIV infection. Materials & methods: During 1 year of tenofovir disoproxil fumarate (TDF) treatment in patients with chronic hepatitis B, we investigated the expression of FoxP3, PD-1 and CTLA-4. Peripheral blood mononuclear cells were isolated from the 30 study subjects at T0 (0 months), T3, T6 and T12 months after the commencement of TDF treatment. Results & conclusion: Expression of FoxP3, PD-1 and CTLA-4 was significantly decreased in T cells of patients with chronic hepatitis B under TDF treatment at T12, when compared with that at T0. A direct correlation was observed between FoxP3 and CTLA-4 expression in patients with chronic hepatitis B and the frequency of FoxP3 was positively associated with serum alanine aminotransferase levels. Cho, Hyosun; Kang, Hyojeung; Kim, Ji Y.; Kim, Hee Y.; Kim, Chang W. Duksung Womens Univ, Dept Pharm, Coll Pharm, Seoul, South Korea; Duksung Womens Univ, Dept Pharm, Duksung Innovat Drug Ctr, Seoul, South Korea; Kyungpook Natl Univ, Coll Pharm, Dept Pharm, Res Inst Pharmaceut Sci, Daegu, South Korea; Kyungpook Natl Univ, Inst Microorganisms, Daegu, South Korea; Catholic Univ Korea, Dept Internal Med, Coll Med, Seoul, South Korea Kim, Chang/G-5001-2015 55572361200; 8979751700; 57219030945; 7410124185; 57212853555 hyosun1102@duksung.ac.kr;cwkim@catholic.ac.kr; FUTURE VIROLOGY FUTURE VIROL 1746-0794 1746-0808 15 4 SCIE VIROLOGY 2020 1.831 87.8 0.05 2025-06-25 2 2 CTLA-4; FoxP3; HBV; PD-1; tenofovir REGULATORY T-CELLS; VIRUS INFECTION; EXPRESSION; HBV; INDUCTION; PATHWAYS; DISEASE; IMPACT CTLA-4; FoxP3; HBV; PD-1; tenofovir alanine aminotransferase; cytotoxic T lymphocyte antigen 4; programmed death 1 ligand 1; tenofovir disoproxil; transcription factor FOXP3; adult; aged; alanine aminotransferase blood level; antiviral therapy; Article; CD4+ T lymphocyte; CD8+ T lymphocyte; cell isolation; chronic hepatitis B; clinical article; controlled study; female; flow cytometry; human; human cell; immunophenotyping; male; patient compliance; peripheral blood mononuclear cell; priority journal; protein expression level; regulatory T lymphocyte; treatment duration; upregulation; virus replication English 2020 2020-04 10.2217/fvl-2019-0128 바로가기 바로가기 바로가기 바로가기
Article High yield recombinant expression and purification of oncogenic NSD1, NSD2, and NSD3 with human influenza hemagglutinin tag The nuclear receptor-binding SET Domain (NSD) family consists of NSD1, NSD2/MMSET/WHSC1, and NSD3/WHSC1L1 histone methyltransferases that are crucial for chromatin remodeling. NSDs are implicated in developmental disorders such as Wolf-Hirschhorn and Sotos syndromes as well as various cancers including t(4; 14)(p16; q32) myeloma, an incurable cancer in plasma cells. NSDs have been the target of intensive study to understand their biological functions more fully and inform anti-cancer drug design. Recombinant protein expression and purification of human NSDs using an E. coli expression system are notoriously challenging, but the production of pure, stable, and active NSDs is essential for further studies. To overcome production challenges, we propose a cost-efficient approach optimized to produce a high yield of NSDs using a modified E. coli expression system. We found that tagging the NSDs with a human influenza hemagglutinin (HA) tag greatly improved the quality of the recombinant NSDs, resulting in more than 95% pure, stable, and active NSD-HAs, with an increase in production yield up to 22.4-fold and up to 6.25 mg/L from LB E. coli culture, and without further purification such as ion-exchange or size-exclusion chromatography. Shen, Yunpeng; Morishita, Masayo; di Luccio, Eric Kyungpook Natl Univ, Coll Nat Sci, Sch Life Sci, Dept Genet Engn, Daegu 41566, South Korea; Kyungpook Natl Univ, Coll Agr & Life Sci, Sch Food Sci & Biotechnol, Daegu 41566, South Korea; Kyungpook Natl Univ, Inst Agr Sci & Technol, Daegu 41566, South Korea di Luccio, Eric/Z-5388-2019 57189042113; 46261422200; 6602656101 masayo.morishita.dl@gmail.com;eric.diluccio@gmail.com; PROTEIN EXPRESSION AND PURIFICATION PROTEIN EXPRES PURIF 1046-5928 1096-0279 166 SCIE BIOCHEMICAL RESEARCH METHODS;BIOCHEMISTRY & MOLECULAR BIOLOGY;BIOTECHNOLOGY & APPLIED MICROBIOLOGY 2020 1.65 87.8 0.21 2025-06-25 5 4 NSD1; NSD2; NSD3; HA-tag; Recombinant expression; Escherichia coli GENE; WHSC1L1 Escherichia coli; HA-tag; NSD1; NSD2; NSD3; Recombinant expression Amino Acid Sequence; Chromatography, Ion Exchange; Escherichia coli; Gene Expression; Genetic Vectors; Hemagglutinin Glycoproteins, Influenza Virus; Histone-Lysine N-Methyltransferase; Humans; Intracellular Signaling Peptides and Proteins; Protein Conformation; Protein Stability; Recombinant Proteins; histone lysine methyltransferase; Influenza virus hemagglutinin; recombinant protein; signal peptide; amino acid sequence; chemistry; enzymology; Escherichia coli; gene expression; gene vector; genetics; human; ion exchange chromatography; protein conformation; protein stability English 2020 2020-02 10.1016/j.pep.2019.105506 바로가기 바로가기 바로가기 바로가기
Article Effect of La0.8Ca0.2Cr0.9Co0.1O3-δ infiltration on the LCCC-YSZ layer as an interconnector material in solid oxide fuel cells Full densification of the interconnector La0.8Ca0.2Cr0.9Co0.1O3-delta (LCCC) layer is hardly achieved when it is screen-printed and cofired on a pre-sintered NiO-YSZ (yttria-stabilized zirconia, 8YSZ) substrate. In this study, the LCCC precursors with different concentrations and viscosities were prepared and infiltrated into the LCCC-YSZ layer. The phase development process and densification behavior of the LCCC were analyzed, and the optimum conditions for full densification are suggested. Through the research, we propose a method for manufacturing a dense LCCC interconnector layer. Lee, Ho-Chang; Lee, Jiwon; Lee, Jung-A; Heo, Young-Woo; Lee, Joon-Hyung; Kim, Jeong-Joo Kyungpook Natl Univ, Sch Mat Sci & Engn, Daegu 41566, South Korea Lee, Jung/AAP-7829-2021; Kim, Jihyun/F-6940-2013 55085509700; 55780416700; 55108410500; 7004298542; 57204923460; 8214705700 joonlee@knu.ac.kr;jjkim@knu.ac.kr; JOURNAL OF CERAMIC PROCESSING RESEARCH J CERAM PROCESS RES 1229-9162 21 2 SCIE MATERIALS SCIENCE, CERAMICS 2020 0.69 87.9 0 2025-06-25 2 1 Sintering; Ceramics; Interconnector; Sol-gel preparation; Infiltration STAINLESS-STEEL SUBSTRATE; DOPED LANTHANUM CHROMITE; COATING LAYER Ceramics; Infiltration; Interconnector; Sintering; Sol-gel preparation English 2020 2020-04 10.36410/jcpr.2020.21.2.208 바로가기 바로가기 바로가기 바로가기
Article Effects of Oral Gargling with Aroma Solution in Psychiatric Inpatients: A Non-Randomized Controlled Trial Purpose: The purpose of this study was to examine the effects of oral gargling with an aromatic solution on xerostomia, objective oral status, and oral health-related quality of life in psychiatric inpatients. Methods: A nonequivalent control group with a non-synchronized design was used in this study. The experimental group (n=34) received oral gargling with an aroma solution, while the control group (n=33) gargled with 0.9% normal saline. Dependent variables were measured at pre-, post-, and follow-up test. Data were analyzed using an chi(2)-test, Fisher's exact probability test, t-tests, and repeated measures ANOVA using SPSS/WIN v.21.0. Results: After the intervention, significant differences were revealed in xerostomia (F=15.30, p<.001), objective oral status (F=38.44, p<.001), and oral health-related quality of life (F=62.70, p<.001) with an interaction effect between group and time. Conclusion: These findings indicate that gargling with an aroma solution is more effective than 0.9% normal saline for the oral health of psychiatric inpatients. Therefore gargling with an aroma can be safely recommended as a brief, economical, and positive intervention in clinical settings. Jung, Yun Ah; Kim, Hee Sook Kyungpook Natl Univ, Coll Nursing, Daegu, South Korea; Kyungpook Natl Univ, Res Inst Nursing Sci, Coll Nursing, 680 Gukchaebosang Ro, Daegu 41944, South Korea Kim, Cheol-Hee/F-6278-2013 57216672367; 58668801200 hskim4114@nate.com; JOURNAL OF KOREAN ACADEMY OF NURSING J KOREAN ACAD NURS 2005-3673 2093-758X 50 2 SCIE;SSCI NURSING 2020 0.984 88.1 0.18 2025-06-25 1 1 Aromatherapy; Psychiatry; Inpatients; Xerostomia; Oral Health ESSENTIAL OIL; MOUTH CARE; HEALTH Aromatherapy; Inpatients; Oral Health; Psychiatry; Xerostomia Adult; Aromatherapy; Female; Humans; Male; Mental Disorders; Middle Aged; Mouthwashes; Oral Health; Quality of Life; Surveys and Questionnaires; Xerostomia; Young Adult; mouthwash; adult; aromatherapy; chemistry; controlled clinical trial; controlled study; female; health; human; male; mental disease; middle aged; pathology; psychology; quality of life; questionnaire; xerostomia; young adult Korean 2020 2020-04 10.4040/jkan.2020.50.2.200 바로가기 바로가기 바로가기 바로가기
Article Qualitative Study on the Experience of Patients with Meniere Disease Purpose: The purpose of this study was to understand and describe the experiences of patients with Meniere disease. Methods: Data were collected from February 19, 2019, to February 5, 2020, through individual in-depth interviews with 13 Meniere patients. Verbatim transcripts were analyzed using Colaizzi's phenomenological analysis. Results: The experiences of patients with Meniere disease were clustered into the following four themes from 22 meaning units: 1) Complex unfamiliar symptoms that shatter both balance of the body and peace of the heart; 2) A disease that medical treatment and health professionals cannot cure; 3) Suffering hardships that cannot be understood by non-Meniere sufferers; and 4) Making daily efforts to become healthier. Symptoms of Meniere disease are life-shattering and depressing because they are neither visible nor easily curable. Over time, as they accepted the reality of living with the disease, the participants would shift their focus from complete symptomatic cure to leading a healthy and more balanced life. Conclusion: This study shows that Meniere disease has a pervasive impact on all aspects of the patients' lives. Patients are prone to experiencing restrictions in their social functioning and activities. They also experience psychosocial problems due to the unseen nature of their symptoms. This study elucidates the experiences of Meniere patients and the need for nursing intervention to help improve their quality of life and ability to self-manage. Lastly, this study shows the need for a coordinated interdisciplinary approach to raising public awareness of the disease. Joung, Woo Joung Kyungpook Natl Univ, Coll Nursing, Res Inst Nursing Sci, Daegu 41944, South Korea 56319847900 godblessed@knu.ac.kr; JOURNAL OF KOREAN ACADEMY OF NURSING J KOREAN ACAD NURS 2005-3673 2093-758X 50 5 SCIE;SSCI NURSING 2020 0.984 88.1 0 2025-06-25 0 0 Meniere Disease; Self-Management; Qualitative Research MENTAL-HEALTH; UNCERTAINTY; INDIVIDUALS; SYMPTOMS; ANXIETY; LIFE Meniere Disease; Qualitative Research; Self-Management Humans; Interviews as Topic; Meniere Disease; Qualitative Research; Quality of Life; Self-Management; human; interview; Meniere disease; psychology; qualitative research; quality of life; self care Korean 2020 2020-10 10.4040/jkan.20115 바로가기 바로가기 바로가기 바로가기
Article HDR image reproduction based on visual achromatic response High-dynamic range image reproduction using tone-mapping algorithms are used for image processing to reduce the dynamic range of a real scene to be displayed on low-dynamic range devices. General tone-mapping methods are associated with the determination of local parameters for tone compression and the halo artifact connected to detail enhancements. This paper proposes a lightness-preserved tone-mapping method and a halo-artifact reduction method based on the property of visual achromatic responses. For the reproduction of the visual perception of the real scene on displays, the sensitivity parameter of the sigmoidal transfer curves is optimized for the lightness-preserved tone mapping, and anti-halo image decomposition method is applied for the halo-artifact reduction. In results, it is confirmed that the proposed method improves the performance of the tone-mapping method effectively. Lee, Geun-Young; Kwon, Hyuk-Ju; Lee, Sung-Hak Kyungpook Natl Univ, Sch Elect Engn, Daegu, South Korea 37048800300; 55169908300; 7601395661 g_y_lee@ee.knu.ac.kr;olin1223@ee.knu.ac.kr;shak2@ee.knu.ac.kr; OPTICAL REVIEW OPT REV 1340-6000 1349-9432 27 4 SCIE OPTICS 2020 0.89 88.4 0.09 2025-06-25 2 2 Tone mapping; Lightness preservation; Halo artifact OBJECTIVE QUALITY ASSESSMENT; TONE REPRODUCTION; ADAPTATION; MODEL Halo artifact; Lightness preservation; Tone mapping English 2020 2020-08 10.1007/s10043-020-00604-w 바로가기 바로가기 바로가기 바로가기
Article Adsorption of Heavy Metals Using Activated Carbon Synthesized from the Residues of Medicinal Herbs In this study, we used activated carbon produced from the biomass recovered from the medicinal plant residue for the adsorption process. This study aimed to investigate its effectiveness to adsorb heavy metals at different activating methods and operating conditions. The carbonized residue was activated using both physical and chemical activations to produce activated carbon. The physical and chemical properties of the prepared activated carbon and iodine adsorption capacity were measured and the performance of the activated carbon as an adsorbent examined. Results showed that the physical activation exhibited optimum operating conditions at the carbonization temperature of 650 degrees C for 60 min and moisture content of 10%. Experimental results on adsorption with synthetic wastewater showed that the optimal operating conditions for the removal of Pb2+, Zn2+, and Cd2+ ions were at pH 5, temperature of 25 degrees C, adsorbent dosage of 5 g/L and contact time of 1.5 h. Adsorption index of the Freundlich adsorption isotherm was higher, and the 1/n values of Cd2+, Pb2+ and Zn2+ ions was 0.37, 0.35 and 0.22, respectively. Results showed that the activated carbon from the sample material exhibited a high regeneration capacity. Yan, C. Z.; Kim, M. G.; Hwang, H. U.; Nzioka, A. M.; Sim, Y. J.; Kim, Y. J. Hubei Univ Automot Technol, Shiyan, Peoples R China; Keimyung Coll Univ, Daegu, South Korea; Kyungpook Natl Univ, Daegu, South Korea; Silla Entech, Daegu, South Korea ; Nzioka, Antony Mutua/Y-4112-2018 57191052533; 57191523939; 57191052477; 57191056730; 57203529016; 55699531200 yjukim@knu.ac.kr; THEORETICAL FOUNDATIONS OF CHEMICAL ENGINEERING THEOR FOUND CHEM EN+ 0040-5795 1608-3431 54 5 SCIE ENGINEERING, CHEMICAL 2020 0.698 88.5 0.24 2025-06-25 7 7 medicinal herb residue; chemical activation; physical activation; activated carbon; heavy metals PLASTIC WASTES; PYROLYSIS; SURFACE activated carbon; chemical activation; heavy metals; medicinal herb residue; physical activation Activated carbon; Carbonization; Chemical activation; Heavy metals; Lead removal (water treatment); Carbonization temperatures; Freundlich adsorption isotherms; Optimal operating conditions; Optimum operating conditions; Physical activation; Physical and chemical properties; Regeneration capacity; Synthetic waste water; Adsorption English 2020 2020-09 10.1134/s0040579520050474 바로가기 바로가기 바로가기 바로가기
Review Low-Cost Magnetic Fe3O4/Chitosan Nanocomposites for Adsorptive Removal of Carcinogenic Diazo Dye The eco-friendly adsorptive removal of Congo red (CR) from aqueous medium using Fe3O4/chitosan nanocomposites was investigated. The nanocomposites were synthesized by using a cost effective reductive precipitation method. The structural characterization of nanocomposties was determined by field emission scanning electron microscopy, thermal gravimetric analysis, fourier transform infrared spectroscopy, and magnetic property measurement system. Successful coating of chitosan on the iron oxide nanoparticles was confirmed by field emission scanning electron microscopy. The synthesized nanocomposites showed a maximum adsorption capacity of 47 mg/g for CR from an aqueous solution. Based on non-linear regression, the Langmuir isotherm fitted the experimental data better than the Freundlich and Tempkin models. The separation factor (R-L) calculated from the Langmuir adsorption isotherm indicated that CR adsorption on the nanocomposites was favorable. The obtained Fe3O4/chitosan nanocomposite is a cost-effective adsorbent and can be easily retrieved from an aqueous solution by a magnet after decontamination of CR. Kadam, Avinash; Jang, Jiseon; Lim, Seong-Rin; Lee, Dae Sung Dongguk Univ, Res Inst Biotechnol & Med Converged Sci, Biomedi Campus, Goyang Si 10326, Gyeonggi Do, South Korea; Kyungpook Natl Univ, Dept Environm Engn, Daegu 41566, South Korea; Korea Radioact Waste Agcy, R&D Inst Radioact Wastes, 174 Gajeong Ro, Daejeon 34129, South Korea; Kangwon Natl Univ, Dept Environm Engn, Chunchon 24341, Gangwon, South Korea 56267499300; 56611137400; 14626162700; 55568524907 srlim@kangwon.ac.kr;daesung@knu.ac.kr; THEORETICAL FOUNDATIONS OF CHEMICAL ENGINEERING THEOR FOUND CHEM EN+ 0040-5795 1608-3431 54 4 SCIE ENGINEERING, CHEMICAL 2020 0.698 88.5 0.14 2025-06-25 9 10 Congo red; magnetic nanoparticles; chitosan; adsorption; reduction precipitation method CONGO RED; PHOTOCATALYTIC DECOLORIZATION; CHITOSAN NANOPARTICLES; EQUILIBRIUM; PARTICLES; KINETICS; OXIDE adsorption; chitosan; Congo red; magnetic nanoparticles; reduction precipitation method Adsorption; Adsorption isotherms; Azo dyes; Cost effectiveness; Costs; Electron emission; Field emission; Field emission microscopes; Fourier transform infrared spectroscopy; Gravimetric analysis; Iron metallography; Magnetic nanoparticles; Magnetite; Nanocomposites; Precipitation (chemical); Scanning electron microscopy; Thermogravimetric analysis; Adsorption capacities; Field emission scanning electron microscopy; Iron oxide nanoparticle; Langmuir adsorption isotherms; Magnetic property measurement systems; Reductive precipitation; Structural characterization; Thermal gravimetric analysis; Iron oxides English 2020 2020-07 10.1134/s0040579520040193 바로가기 바로가기 바로가기 바로가기
Article Treatment with AAV1-Rheb(S16H) provides neuroprotection in a mouse model of photothrombosis-induced ischemic stroke We recently reported that upregulation of the constitutively active ras homolog enriched in brain [Rheb(S16H)], which induces the activation of the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway, can protect adult neurons, mediated by the induction of neurotrophic factors, such as brain-derived neurotrophic factor (BDNF), in animal models of neurodegenerative diseases. Here we show that neuronal transduction of Rheb(S16H) using adeno-associated virus serotype 1 provides neuroprotection in a mouse model of photothrombosis-induced ischemic stroke. Rheb(S16H)-expressing neurons exhibited neurotrophic effects, such as mTORC1 activation, increases in neuronal size, and BDNF production, in mouse cerebral cortex. Moreover, the upregulation of neuronal Rheb(S16H) significantly attenuated ischemic damage and behavioral impairments as compared to untreated mice, suggesting that Rheb(S16H) upregulation in cortical neurons may be a useful strategy to treat ischemic stroke. Yoon, Dongyeong; Jeon, Min-Tae; Kim, Dong Woon; Kim, Sang Ryong Kyungpook Natl Univ, Sch Life Sci, Daegu 41566, South Korea; Kyungpook Natl Univ, BK21 Plus KNU Creat BioRes Grp, Daegu, South Korea; Chungnam Natl Univ, Brain Res Inst, Dept Anat, Sch Med, Daejeon, South Korea; Kyungpook Natl Univ, Brain Sci & Engn Inst, Daegu, South Korea 57214744587; 56018969800; 57204150578; 56486163800 srk75@knu.ac.kr; NEUROREPORT NEUROREPORT 0959-4965 1473-558X 31 13 SCIE NEUROSCIENCES 2020 1.837 88.5 0.37 2025-06-25 8 7 brain-derived neurotrophic factor; neuroprotection; Rheb(S16H); stroke FUNCTIONAL RECOVERY; NEUROTROPHIC FACTOR; AAV1 TRANSDUCTION; NEURONS; BRAIN; BDNF; HRHEB(S16H); PROTECTS; ROLES brain-derived neurotrophic factor; neuroprotection; Rheb(S16H); stroke Animals; Brain-Derived Neurotrophic Factor; Cell Enlargement; Dependovirus; Disease Models, Animal; Fluorescent Dyes; Gait Analysis; Gene Transfer Techniques; Genetic Vectors; Ischemic Stroke; Mice; Motor Cortex; Mutation; Neurons; Neuroprotection; Ras Homolog Enriched in Brain Protein; Rose Bengal; Thrombotic Stroke; Transduction, Genetic; adeno associated virus vector; brain derived neurotrophic factor; mammalian target of rapamycin complex 1; neuroprotective agent; Rheb protein; Bdnf protein, mouse; brain derived neurotrophic factor; fluorescent dye; Rheb protein; rose bengal; Adeno associated virus 1; adult; animal cell; animal experiment; animal model; animal tissue; Article; behavior disorder; brain cell; brain cortex; controlled study; enzyme activation; functional disease; in vivo study; infant; male; mouse; neuroprotection; nonhuman; photothrombotic stroke; priority journal; protein expression; serotype; signal transduction; upregulation; animal; brain ischemia; cell enlargement; Dependoparvovirus; disease model; gait; gene transfer; gene vector; genetic transduction; genetics; metabolism; motor cortex; mutation; nerve cell; neuroprotection; pathology; pathophysiology English 2020 2020-09-09 10.1097/wnr.0000000000001506 바로가기 바로가기 바로가기 바로가기
Article Characterization of red ginseng-drug interaction by CYP3A activity increased in high dose administration in mice Ginseng (Panax ginsengMeyer) is a popular traditional herbal medicine used worldwide. Patients often take ginseng preparations with other medicines where the ginseng dose could exceed the recommended dose during long-term administration. However, ginseng-drug interactions at high doses of ginseng are poorly understood. This study showed the possibility of herb-drug interactions between the Korean red ginseng (KRG) extract and cytochrome P450 (CYP) substrates in higher administration in mice. The CYP activities were determined in vivo after oral administration of KRG extract doses of 0.5, 1.0, and 2.0 g/kg for 2 or 4 weeks by monitoring the concentration of five CYP substrates/metabolites in the blood. The area under the curve for OH-midazolam/midazolam catalysed by CYP3A was increased significantly by the administration of 2.0 g/kg KRG extract for 2 and 4 weeks. CYP3A-catalysed midazolam 1MODIFIER LETTER PRIME-hydroxylation also increased significantly in a dose- and time-dependent manner in the S9 fraction of mouse liver which was not related to induction by transcription. Whereas CYP2D-catalysed dextromethorphanO-deethylation decreased in a dose- and time-dependent manner in vivo. In conclusion, interactions were observed between KRG extract and CYP2D and CYP3A substrates at subchronic-high doses of KRG administration in mice. Kim, Younah; Jo, Jung Jae; Cho, Piljoung; Shrestha, Riya; Kim, Kyu Min; Ki, Sung Hwan; Song, Kyung-Sik; Liu, Kwang-Hyeon; Song, Im-Sook; Kim, Ju-Hyun; Lee, Jae-Mok; Lee, Sangkyu Kyungpook Natl Univ, Coll Pharm, BK21 Plus KNU Multiom Based Creat Drug Res Team, Daegu, South Korea; Kyungpook Natl Univ, Res Inst Pharmaceut Sci, Daegu, South Korea; Chosun Univ, Coll Pharm, Gwangju, South Korea; Yeungnam Univ, Coll Pharm, Gyongsan, South Korea; Kyungpook Natl Univ, Sch Dent, Dept Periodontol, 2177 Dalgubeol Daero, Daegu 41940, South Korea; Kyungpook Natl Univ, Coll Pharm, Daegu 702701, South Korea kim, kyumin/KDN-4319-2024; Shrestha, Riya/JCE-7436-2023 57211893872; 57191892087; 57202163312; 57193350367; 56441871900; 8346836500; 13310139000; 55768214700; 7201564500; 55720031300; 17346330000; 57209046767 leejm@knu.ac.kr;sangkyu@knu.ac.kr; BIOPHARMACEUTICS & DRUG DISPOSITION BIOPHARM DRUG DISPOS 0142-2782 1099-081X 41 7 SCIE PHARMACOLOGY & PHARMACY 2020 1.627 88.6 0.69 2025-06-25 8 8 ginseng-drug interaction; LC-MS; MS; pharmacokinetics; red ginseng extract ST-JOHNS-WORT; PANAX-GINSENG; CYTOCHROMES P450; GINSENOSIDES; METABOLISM; INDUCTION; MIDAZOLAM; BIOTRANSFORMATION; INHIBITION; MOUSE ginseng–drug interaction; LC-MS/MS; pharmacokinetics; red ginseng extract Administration, Oral; Animals; Area Under Curve; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Dextromethorphan; Dose-Response Relationship, Drug; Herb-Drug Interactions; Male; Mice; Midazolam; Panax; Plant Extracts; Time Factors; amfebutamone; caffeine; cytochrome P450 1A; cytochrome P450 2A; cytochrome P450 2B; cytochrome P450 2C; cytochrome P450 2D; cytochrome P450 3A; cytochrome P450 3A11; dextromethorphan; ginseng extract; ginsenoside Rb 1; ginsenoside Rb 2; ginsenoside Rc; ginsenoside Rd; ginsenoside Re; ginsenoside Rf; ginsenoside Rf 1; ginsenoside Rf 2; ginsenoside Rg 1; ginsenoside Rg 3; ginsenoside Rh 2; midazolam; omeprazole; protopanaxadiol; protopanaxatriol; reduced nicotinamide adenine dinucleotide phosphate; unclassified drug; CYP3A protein, mouse; cytochrome P450; cytochrome P450 3A; cytochrome P450 family 2; dextromethorphan; midazolam; plant extract; animal experiment; animal model; animal tissue; area under the curve; Article; blood analysis; catalysis; concentration process; controlled study; drug hydroxylation; drug megadose; ginseng; herb drug interaction; in vivo study; liver tissue; male; mouse; nonhuman; recommended drug dose; synergistic effect; animal; chemistry; dose response; metabolism; oral drug administration; Panax; time factor English 2020 2020-07 10.1002/bdd.2246 바로가기 바로가기 바로가기 바로가기
Article Deoxyshikonin reversibly inhibits cytochrome P450 2B6 Deoxyshikonin, a natural shikonin derivative, is the major component of Lithospermum erythrorhizon and exhibits various pharmacological effects such as lymphangiogenetic, antibacterial, wound healing, and anticancer effects. To investigate the herb-drug interaction potential associated with deoxyshikonin, the inhibitory effects of deoxyshikonin on eight major cytochrome P450 (CYP) enzymes were examined using cocktail substrate-incubated human liver microsomes. Deoxyshikonin strongly inhibited CYP2B6-catalyzed bupropion hydroxylation, with a K-i value of 3.5 mu M, and the inhibition was confirmed using purified human CYP2B6. The inhibition was reversible because the inhibitory effect of deoxyshikonin was not dependent on the preincubation time. The results indicated that deoxyshikonin-induced drug-drug interaction should be considered when any herb containing deoxyshikonin is used for conventional medications. Kim, Ju-Hyun; Choi, Su Min; Shreatha, Riya; Jeong, Gil-Saeng; Jeong, Tae Cheon; Lee, Sangkyu Yeungnam Univ, Coll Pharm, Gyongsan 38541, South Korea; Kyungpook Natl Univ, BK21 Plus KNU Multiom Based Creat Drug Res Team, Coll Pharm, Daegu 41566, South Korea; Kyungpook Natl Univ, Pharmaceut Sci Res Inst, Daegu 41566, South Korea; Keimyung Univ, Coll Pharm, Daegu 42601, South Korea 55720031300; 57212768203; 57216866921; 57204396456; 7102759745; 57209046767 sangkyu@knu.ac.kr; BIOPHARMACEUTICS & DRUG DISPOSITION BIOPHARM DRUG DISPOS 0142-2782 1099-081X 41 4-5 SCIE PHARMACOLOGY & PHARMACY 2020 1.627 88.6 0.1 2025-06-25 2 2 deoxyshikonin; herb-drug interaction; reversible inhibition IN-VITRO; DRUG INTERACTIONS; HYDROXYLATION; METABOLISM; SHIKONIN; BUPROPION; P4502B6; RISK cytochrome P450 2B6; deoxyshikonin; herb–drug interaction; reversible inhibition Cytochrome P-450 CYP2B6 Inhibitors; Cytochrome P-450 Enzyme System; Herb-Drug Interactions; Humans; Microsomes, Liver; Naphthoquinones; amfebutamone; amodiaquine; coumarin; cytochrome P450 1A2; cytochrome P450 2A6; cytochrome P450 2B6; cytochrome P450 2C19; cytochrome P450 2C8; cytochrome P450 2C9; cytochrome P450 2D6; cytochrome P450 2E1; cytochrome P450 2J2; cytochrome P450 3A; cytochrome P450 3A4; cytochrome P450 inhibitor; deoxyshikonin; dextromethorphan; diclofenac; midazolam; omeprazole; phenacetin; shikonin derivative; thiotepa; unclassified drug; cytochrome P450; cytochrome P450 2B6 inhibitor; deoxyshikonin; naphthoquinone; Article; enzyme inhibition; herb drug interaction; human; human cell; hydroxylation; IC50; incubation time; inhibition constant; inhibition kinetics; liver microsome; multiple reaction monitoring; plasma protein binding; time-dependent inhibition; herb drug interaction; metabolism English 2020 2020 (APR-MAY) 10.1002/bdd.2230 바로가기 바로가기 바로가기 바로가기
페이지 이동:

논문 데이터 용어 설명

용어 설명
WoS Web of Science. Clarivate Analytics에서 제공하는 학술 데이터베이스입니다. 해당 논문이 WoS에 수록되어 있는지 여부를 표시합니다 (○: 수록됨).
SCOPUS Elsevier에서 제공하는 세계 최대 규모의 초록 및 인용 데이터베이스입니다. 해당 논문이 SCOPUS에 수록되어 있는지 여부를 표시합니다 (○: 수록됨).
Document Type 문헌의 유형을 나타냅니다. Article(원저), Review(리뷰), Proceeding Paper(학회논문), Editorial Material(편집자료), Letter(레터) 등으로 분류됩니다.
Title 논문의 제목입니다.
Abstract 논문의 초록(요약)입니다. 연구의 목적, 방법, 결과, 결론을 간략히 요약한 내용입니다.
Authors 논문의 저자 목록입니다. 공동 저자가 여러 명인 경우 세미콜론(;)으로 구분됩니다.
Affiliation 저자들의 소속 기관 정보입니다. 대학, 연구소, 기업 등 저자가 소속된 기관명이 표시됩니다.
ResearcherID (WoS) Web of Science의 고유 연구자 식별번호입니다. 동명이인을 구분하고 연구자의 업적을 정확하게 추적할 수 있습니다.
AuthorsID (SCOPUS) SCOPUS의 고유 저자 식별번호입니다. 연구자의 모든 출판물을 추적하고 관리하는 데 사용됩니다.
Journal 논문이 게재된 학술지의 정식 명칭입니다.
JCR Abbreviation Journal Citation Reports에서 사용하는 저널의 공식 약어입니다. 저널을 간략하게 표기할 때 사용됩니다.
ISSN International Standard Serial Number. 국제표준연속간행물번호로, 인쇄본 저널에 부여되는 고유 식별번호입니다.
eISSN Electronic ISSN. 전자 버전 저널에 부여되는 고유 식별번호입니다.
Volume 저널의 권(Volume) 번호입니다. 보통 연도별로 하나의 권이 부여됩니다.
Issue 저널의 호(Issue) 번호입니다. 한 권 내에서 여러 호로 나누어 출판되는 경우가 많습니다.
WoS Edition Web of Science의 에디션입니다. SCIE(Science Citation Index Expanded), SSCI(Social Sciences Citation Index), AHCI(Arts & Humanities Citation Index) 등으로 구분됩니다.
WoS Category Web of Science의 주제 분류 카테고리입니다. 저널과 논문이 속한 학문 분야를 나타냅니다.
JCR Year 해당 저널의 JCR(Journal Citation Reports) 지표가 산출된 연도입니다.
IF (Impact Factor) 저널 영향력 지수. 최근 2년간 발표된 논문이 해당 연도에 평균적으로 인용된 횟수를 나타냅니다. 저널의 학술적 영향력을 나타내는 대표적인 지표입니다.
JCR (%) 해당 카테고리에서 저널이 위치하는 상위 백분율입니다. 값이 낮을수록 우수한 저널임을 의미합니다 (예: 5%는 상위 5%를 의미).
FWCI Field-Weighted Citation Impact. 분야별 가중 인용 영향력 지수입니다. 논문이 받은 인용을 동일 분야, 동일 연도, 동일 문헌 유형의 평균과 비교한 값입니다. 1.0이 평균이며, 1.0보다 높으면 평균 이상의 인용을 받았음을 의미합니다.
FWCI UpdateDate FWCI 값이 마지막으로 업데이트된 날짜입니다. FWCI는 인용이 누적됨에 따라 주기적으로 업데이트됩니다.
WOS Citation Web of Science에서 집계된 해당 논문의 총 인용 횟수입니다.
SCOPUS Citation SCOPUS에서 집계된 해당 논문의 총 인용 횟수입니다.
Keywords (WoS) 저자가 논문에서 직접 지정한 키워드입니다. Web of Science에 등록된 저자 키워드 목록입니다.
KeywordsPlus (WoS) Web of Science에서 자동으로 추출한 추가 키워드입니다. 논문의 참고문헌 제목에서 자주 등장하는 단어들로 생성됩니다.
Keywords (SCOPUS) 저자가 논문에서 직접 지정한 키워드입니다. SCOPUS에 등록된 저자 키워드 목록입니다.
KeywordsPlus (SCOPUS) SCOPUS에서 자동으로 추출하거나 추가한 색인 키워드입니다.
Language 논문이 작성된 언어입니다. 대부분 English이며, 그 외 다양한 언어로 작성된 논문이 포함될 수 있습니다.
Publication Year 논문이 출판된 연도입니다.
Publication Date 논문의 정확한 출판 날짜입니다 (년-월-일 형식).
DOI Digital Object Identifier. 디지털 객체 식별자로, 논문을 고유하게 식별하는 영구적인 식별번호입니다. 이를 통해 논문의 온라인 위치를 찾을 수 있습니다.